Published

The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A Narrative Review

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Lynchburg Journal of Medical Science
Date: 2026-08-20
Source: Crossref
DOI: 10.63932/3067-7106.1087
PubMed: Unavailable

Authors

Clark Rachel N

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Addiction Pharmacology Receptor Pharmacology Aging Clinical Trial Review Article Safety Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A Narrative Review2026-08-20

Related papers

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's DiseaseClinicalTrials.gov · 2026-08-07 Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-05-01 Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring OpioidsClinicalTrials.gov · 2026-08-12 Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal CortexEuropean Journal of Neuroscience · 2026-06-01 An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in LifeClinicalTrials.gov · 2026-08-17 The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-08-01 The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive DisorderClinicalTrials.gov · 2026-08-13 Psilocybin-Assisted Therapy for Prolonged GriefClinicalTrials.gov · 2026-06-23